To evaluate whether in vitro depletion of MGMT in human GBM, GSCs, and melanoma regulated their radioresponse, clonogenic survival assays were performed and showed that the radiosensitivity of each MGMT(−) cell line was significantly different when MGMT was depleted or inhibited. The gene discussed is MGMT; the disease is glioblastoma.